CD8A and neoplasm: These localized microbes can alter the therapeutic effect of anticancer drugs through the expression of enzymes that are capable of metabolizing such drugs (e.g., dihydropyrimidine dehydrogenase [51]), by modulating autophagy [114], or enhancing tumor-infiltration and activation of CD8+ T cells [115].